132 related articles for article (PubMed ID: 32813242)
1. Enrichment and Transcriptional Characterization of Stem Cells Isolated from Human Glioblastoma Cell Lines.
Piña-Medina AG; Hernández-Vega AM; Díaz NF; Mancilla-Herrera I; Camacho-Arroyo I
Methods Mol Biol; 2021; 2174():19-29. PubMed ID: 32813242
[TBL] [Abstract][Full Text] [Related]
2. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
[TBL] [Abstract][Full Text] [Related]
3. Effects of progesterone on the cell number of gliomaspheres derived from human glioblastoma cell lines.
Piña-Medina AG; Díaz NF; Molina-Hernández A; Mancilla-Herrera I; Camacho-Arroyo I
Life Sci; 2020 May; 249():117536. PubMed ID: 32165211
[TBL] [Abstract][Full Text] [Related]
4. Characterization of glioma stem-like cells from human glioblastomas.
Yamamuro S; Okamoto Y; Sano E; Ochiai Y; Ogino A; Ohta T; Hara H; Ueda T; Nakayama T; Yoshino A; Katayama Y
Int J Oncol; 2015 Jul; 47(1):91-6. PubMed ID: 25955568
[TBL] [Abstract][Full Text] [Related]
5. Selective lentiviral gene delivery to CD133-expressing human glioblastoma stem cells.
Bayin NS; Modrek AS; Dietrich A; Lebowitz J; Abel T; Song HR; Schober M; Zagzag D; Buchholz CJ; Chao MV; Placantonakis DG
PLoS One; 2014; 9(12):e116114. PubMed ID: 25541984
[TBL] [Abstract][Full Text] [Related]
6. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
[TBL] [Abstract][Full Text] [Related]
7. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
[TBL] [Abstract][Full Text] [Related]
8. CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.
Chiao MT; Yang YC; Cheng WY; Shen CC; Ko JL
Curr Neurovasc Res; 2011 Aug; 8(3):210-9. PubMed ID: 21675958
[TBL] [Abstract][Full Text] [Related]
9. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
10. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
[TBL] [Abstract][Full Text] [Related]
11. Girdin maintains the stemness of glioblastoma stem cells.
Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous phenotype of human glioblastoma: in vitro study.
Denysenko T; Gennero L; Juenemann C; Morra I; Masperi P; Ceroni V; Pragliola A; Ponzetto A; Melcarne A
Cell Biochem Funct; 2014 Mar; 32(2):164-76. PubMed ID: 23836332
[TBL] [Abstract][Full Text] [Related]
13. Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells.
Yamamuro S; Sano E; Okamoto Y; Ochiai Y; Ohta T; Ogino A; Natsume A; Wakabayashi T; Ueda T; Hara H; Nakayama T; Yoshino A; Katayama Y
Int J Oncol; 2015 Nov; 47(5):1647-54. PubMed ID: 26397698
[TBL] [Abstract][Full Text] [Related]
14. Effect of Notch expression in glioma stem cells on therapeutic response to chemo-radiotherapy in recurrent glioblastoma.
Saito N; Aoki K; Hirai N; Fujita S; Iwama J; Hiramoto Y; Ishii M; Sato K; Nakayama H; Harashina J; Hayashi M; Izukura H; Kimura H; Ito K; Sakurai T; Yokouchi Y; Oharazeki T; Takahashi K; Iwabuchi S
Brain Tumor Pathol; 2015 Jul; 32(3):176-83. PubMed ID: 25665548
[TBL] [Abstract][Full Text] [Related]
15. Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1.
Bageritz J; Puccio L; Piro RM; Hovestadt V; Phillips E; Pankert T; Lohr J; Herold-Mende C; Lichter P; Goidts V
Cell Death Differ; 2014 Jun; 21(6):929-40. PubMed ID: 24531536
[TBL] [Abstract][Full Text] [Related]
16. Expression of multidrug resistance genes in normal and cancer stem cells.
Shervington A; Lu C
Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
[TBL] [Abstract][Full Text] [Related]
17. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
[TBL] [Abstract][Full Text] [Related]
18. Isolation and partial characterization of a new human glioblastoma cell line.
Brehar FM; Bleotu C; Stefan LM; Buzgariu W; Chivu M; Utoiu E; Matei L; Ciurea AV; Tascu A
Chirurgia (Bucur); 2009; 104(4):453-61. PubMed ID: 19886054
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Large-Conductance Calcium-Activated Potassium Channels in Human Glioblastoma Stem-Like Cells and Their Role in Cell Migration.
Rosa P; Sforna L; Carlomagno S; Mangino G; Miscusi M; Pessia M; Franciolini F; Calogero A; Catacuzzeno L
J Cell Physiol; 2017 Sep; 232(9):2478-2488. PubMed ID: 27606467
[TBL] [Abstract][Full Text] [Related]
20. Astrocytes enhance the invasion potential of glioblastoma stem-like cells.
Rath BH; Fair JM; Jamal M; Camphausen K; Tofilon PJ
PLoS One; 2013; 8(1):e54752. PubMed ID: 23349962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
